PURE-PLAY CRO CAPABILITIES

Our Core Services & Areas of Expertise

Building the next generation of CRO services, combining clinical expertise, real-world data, biospecimens, and digital intelligence to deliver smarter, more efficient research.

Domain 01

Phase IV & Post-Marketing Research

Post-marketing clinical research, safety monitoring, efficacy validation, and observational programs in real-world clinical settings.

Post-Marketing Safety Monitoring

Systematic monitoring of adverse events and long-term drug tolerability across extensive, diverse patient cohorts.

Efficacy Validation in Real Practice

Evaluating therapy response rates and clinical endpoints outside the restrictive criteria of pre-marketing trials.

Observational Clinical Programs

Non-interventional study designs documenting standard-of-care patient pathways across multi-center hospital networks.

Regulatory Commitment Studies

Fulfilling post-authorization safety study (PASS) and efficacy study (PAES) regulatory obligations with CDSCO, FDA, and EMA rigor.

Consult with our Phase IV Specialists
Phase IV and Post-Marketing Research

Real-World Safety & Vigilance

Tapping into 50+ hospital networks established since 2012, our team coordinates physician investigators to track patient outcomes and generate post-launch evidence swiftly.

Seamless Investigator Engagement
Longitudinal Patient Retention
CDSCO-Compliant Ethical Clearances
Real-World Evidence & Epidemiology

Bridging Clinical Trials & Real Practice

Randomized clinical trials provide essential proof of efficacy, but real-world evidence illuminates how therapies perform in heterogeneous, multimorbid patient populations across Indian healthcare settings.

Comparative Effectiveness Analysis
Health Economics & Outcomes Research (HEOR)
Epidemiological Disease Burden Mapping
Domain 02

Real-World Evidence & Epidemiology

Designing and managing non-interventional studies, observational cohorts, and epidemiological research reflecting diverse patient populations.

Non-Interventional Study Design

Scientifically rigorous protocols without treatment interference, preserving authentic clinical practice dynamics.

Epidemiological Cohorts

Characterizing incidence, prevalence, risk factors, and prognostic markers across India's diverse demographic landscape.

Treatment Pattern Analytics

Uncovering prescribing habits, medication adherence rates, line of therapy progressions, and clinical switches.

Payor & Market Access Evidence

Generating compelling real-world value dossiers to support reimbursement decisions and health policy dialogues.

Initiate an RWE Program
Biospecimen Repository and Cold Chain
Domain 03

Biospecimen-Based Research & Biobanking

Procurement, ethical management, and scientific characterization of high-quality biospecimens supporting diagnostics and translational research.

Ethical Informed Consent: Double-witnessed patient consent under strict ICMR, GCP, and international bioethics guidelines.
Validated Cold Chain: Continuous telemetry logging from collection bedside to -80°C mechanical storage and liquid nitrogen vapor phase.
Barcode Chain-of-Custody: Digital 2D barcode sample tracking linked to annotated clinical metadata.
Request Biospecimen Sourcing Specifications
Available Bio-Matrices

Extensive Repository Categories

Human Tissues

  • • Fresh frozen surgical resections
  • • Validated FFPE tissue blocks
  • • Histopathology glass slides
  • • Matched tumor & adjacent normal

Liquid Biofluids

  • • Whole blood & blood derivatives
  • • Matched serum & plasma aliquots
  • • Cerebrospinal fluid (CSF)
  • • Urine, saliva, and synovial fluids

Primary Cells

  • • High viability isolated PBMCs
  • • Viable buffy coat fractions
  • • Bone marrow mononuclear cells (BMMC)
  • • CD4+/CD8+ immunomagnetic isolations

Molecular Targets

  • • High-molecular-weight genomic DNA
  • • Total RNA & small microRNA
  • • Circulating cell-free DNA (cfDNA)
  • • Extracted total cellular protein

Remnant Clinicals

  • • Biomarker-characterized panels
  • • Diagnostic concordance cohorts
  • • Longitudinal patient follow-up vials
  • • Standard clinical pathology archives
Domain 04

Clinical Data Collection & Observational Studies

Systematic clinical data gathering across multi-center networks, supporting real-world insights, disease modeling, and drug performance.

Multi-Center Data Harvesting

Standardized electronic case report forms (eCRF) deployed across hospital sites for high-accuracy data capture.

Disease Modeling & Trajectory

Longitudinal follow-ups tracking biomarker progression, symptom severity, and prognostic transitions over time.

Patient-Reported Outcomes (PRO)

Capturing quality of life, functional status, and treatment satisfaction metrics directly from patients.

Quality Control & Validation

Source data verification, query resolution, automated validation rules, and rigorous auditing ensure analysis readiness.

Discuss Data Collection Protocols
Clinical Data Collection & Disease Mechanisms

Structured Real-World Datasets

Our site coordinators work directly inside clinical environments to ensure continuous data entry, eliminating missing values and standardizing clinical definitions.

MedDRA & WHO Drug Coding
GCP-Compliant Audit Trails
Centralized Remote Monitoring
Patient Registries & Disease Cohort Tracking

Longitudinal Registry Power

Patient registries provide the definitive clinical anchor for rare diseases, oncology survivorship, and chronic therapeutic management.

Multi-Year Patient Follow-Ups
Rare Disease & Orphan Indication Cohorts
Clinical Practice Variation Insights
Domain 05

Patient Registries & Outcomes Research

Building disease-specific patient registries and longitudinal outcome studies to evaluate treatment patterns, patient outcomes, and burden of illness.

Disease-Specific Registries

Dedicated longitudinal platforms for Oncology, Neurology, Metabolic Diseases, and autoimmune disorders.

Outcomes & Burden of Illness

Quantifying direct medical costs, disability-adjusted life years, and long-term societal burden across conditions.

Real-World Survival Analysis

Tracking progression-free survival (PFS) and overall survival (OS) in actual clinic settings over extended durations.

Physician Decision Insights

Uncovering treatment heterogeneity, guideline adherence, and unmet medical needs among clinicians.

Establish a Patient Registry
Domain 06

Diagnostics & Biomarker Research

Facilitating diagnostic validation, biomarker identification, and translational research through coordinated clinical sample collection and Contract Diagnostic Organization (CDO) execution.

IVD & CDx Clinical Trials

Supporting in-vitro diagnostic and companion diagnostic approvals with prospective patient testing.

Analytical & Clinical Specificity

Robust testing of limit of detection (LoD), sensitivity, cross-reactivity, and reproducibility.

Central Laboratory Processing

Fractionation, PBMC isolation, molecular profiling (RT-PCR, NGS, ELISA multiplex, flow cytometry).

Biomarker Discovery Support

Coordinating matched disease and normal cohorts for genetic, proteomic, and metabolic biomarker screening.

Partner on Diagnostic Studies
Diagnostics & Biomarker Research
Cosmetic & Dermatology Studies

Dermatological & Cosmetic Excellence

Conducting human clinical trials under board-certified dermatologists, providing objective biometric evidence and consumer perception data for regulatory and market claims.

Board-Certified Dermatologists
Non-Invasive Skin Bio-Instrumentation
Stringent Safety & HRIPT Testing
Domain 07

Cosmetic & Dermatology Studies

Clinical evaluation, dermatological safety assessments, and efficacy studies for cosmetic products, dermatological formulations, and aesthetic treatments.

Dermatological Safety Assessments

HRIPT (Human Repeat Insult Patch Test), primary irritation patch tests, photo-toxicity, and ocular safety validations.

Clinical Efficacy & Claim Substantiation

Validating anti-aging, hydration, skin barrier repair, depigmentation, elasticity, and sebum regulation claims.

Dermatological Formulations

Clinical trials for therapeutic topicals treating acne, psoriasis, eczema, atopic dermatitis, and alopecia.

Aesthetic & Device Treatments

Assessing lasers, microneedling devices, skin peels, and aesthetic dermal procedures under expert clinical supervision.

Explore Cosmetic & Dermatology Trials
Our Operating Framework

4-Step Operational Workflow

01

Protocol Intake

Submit your clinical trial protocols, cohort parameters, biomarker targets, or post-marketing research objectives.

02

Site & Ethical Setup

Deploy protocols across trusted investigator and hospital networks under verified IRB and Informed Consent guidelines.

03

Execution & Telemetry

Active patient recruitment, observational data capture, and low-temperature biobanking with 24/7 telemetry logs.

04

Validated Delivery

Delivery of clean, analysis-ready clinical datasets, verified biospecimens, and regulatory study summary reports.

WhatsApp Chat Call Headquarters